Arabesque Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-22,653
Closed -$1.69M 53
2022
Q4
$1.69M Hold
22,653
0.57% 85
2022
Q3
$1.87M Sell
22,653
-13,855
-38% -$1.33M 0.91% 71
2022
Q2
$3.47M Sell
36,508
-1,380
-4% -$143K 1.83% 3
2022
Q1
$4.46M Sell
37,888
-991
-3% -$111K 1.55% 7
2021
Q4
$5.04M Buy
38,879
+18,904
+95% +$2.21M 1.45% 6
2021
Q3
$2.26M Buy
19,975
+17,156
+609% +$1.96M 0.76% 47
2021
Q2
$292K Sell
2,819
-13,767
-83% -$1.3M 0.12% 120
2021
Q1
$1.39M Buy
16,586
+1,586
+11% +$134K 0.61% 51
2020
Q4
$1.37M Sell
15,000
-7,919
-35% -$657K 0.41% 43
2020
Q3
$1.83M Buy
+22,919
New +$1.79M 1.64% 35
2020
Q1
Sell
-50,133
Closed -$3.9M 71
2019
Q4
$3.9M Buy
50,133
+5,811
+13% +$454K 1.5% 13
2019
Q3
$3.25M Buy
44,322
+20,022
+82% +$1.41M 1.5% 25
2019
Q2
$1.5M Buy
+24,300
New +$1.47M 0.68% 68

Other funds holding EW

Arabesque Asset Management's EW Position: Q1 2023 in Review

Arabesque Asset Management sold out of Edwards Lifesciences (EW) in Q1 2023, closing a stake of 22,653 shares — an estimated $1.69M sold.

Arabesque Asset Management first reported a position in EW in Q2 2019 and held it in 13 quarters. The position peaked at $5.04M in Q4 2021. 1,246 funds tracked by Wall St. Rank hold EW as of Q1 2023.

  • Arabesque Asset Management reported no remaining Edwards Lifesciences position as of Q1 2023 after selling out during the quarter.
  • Arabesque Asset Management sold 22,653 Edwards Lifesciences shares in Q1 2023, an estimated $1.69M.
  • Arabesque Asset Management first reported a position in Edwards Lifesciences in Q2 2019 and held it in 13 quarters.
  • Arabesque Asset Management's Edwards Lifesciences position peaked at $5.04M in Q4 2021.
  • 1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2023.

Based on Arabesque Asset Management's 13F filing for Q1 2023.